Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone

R. Tanosaki, H. Uchida, Y. Masuda, N. Michikawa, T. Ogawa, A. Kubo, Y. Ikeda

研究成果: Article査読

1 被引用数 (Scopus)

抄録

A 64 year-old female patient of idiopathic myelofibrosis (IMF), who had had rapidly progressing massive splenomegaly and severe pancytopenia refractory to blood transfusion, was treated with PSL 0.6 mg/kg/day for a month, being significantly improved not only symptomatically and hematologically but also in bone marrow hematopoiesis. Although the effectiveness of PSL to restoration of bone marrow hematopoiesis has been almost unknown, long term oral PSL should be tried for a certain phase of IMF.

本文言語English
ページ(範囲)256-258
ページ数3
ジャーナル[Rinshō ketsueki] The Japanese journal of clinical hematology
33
2
出版ステータスPublished - 1992 2月

ASJC Scopus subject areas

  • 医学(全般)

フィンガープリント

「Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル